PTGS2 and cancer: Through the organoid experiments, we found that mutant p53R270H–expressing cells transactivate Wnt/β-catenin signaling of co-cultured Trp53−/− cancer cells through induction of the COX-2/prostaglandin E2 (PGE2) pathway.